High Purity Nootropics CAS 22503-72-6 99%

High Purity Nootropics CAS 22503-72-6 99%

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 1050.0000 -1100.0000

1 Kilogram

FOB Price:USD 1050.0000 -1100.0000

Min.Order :1 Kilogram
Purity: 100% HPLC-MS
Payment Terms : T/T,Other

Keywords

22503-72-6 Nootropics IDRA 21

Quick Details

Appearance:white or white crystalline powder
Application:Pharmaceutical Intermediate
PackAge:1kg/bag;25kg/drum
ProductionCapacity:300|Kilogram|Month
Storage:Dry and cold condition
Transportation:by express or by air

Superiority:

  We guarantee that 100% of your parcel passes through the United States, Britain, Australia, Canada, Mexico, France, Germany, Spain, Belgium, Sweden, Poland, and Russia.  We have large stocks in warehouses in the United States, Canada, Germany, and Mexico, and we can ship directly from overseas warehouses.
     We have powerful customs clearance agencies in these countries, and our customs clearance company will clear your parcel without any customs issues, sometimes even 1000 kg.  Door to door service DDP service.  To ensure 100% receipt of your package, if there are any customs issues, we are willing to reissue your package free of charge.  Let you have a good experience of our strong shipping capabilities.
     We have many customers in the United States, Canada, Mexico, Australia, United Kingdom, and European Union countries and retain long-term cooperation.  Provide a large number of high-quality products.  They made a lot of money.  I am sure we can make more money together.  There is money to have glory.

Details:

High Quality Manufacturer Supply Idra-21 Idra21 22503-72-6 Idra 21

Product Name	IDRA-21	Appearance	White powder
Molecular Formula	C8H9ClN2O2S	Molecular Weight	232.687
Cas No.	22503-72-6	Boling Point	405.1±55.0 °C at 760 mmHg
Flashing Point	198.8±31.5 °C	Density	1.4±0.1 g/cm3

IDRA-21 is a relatively new nootropic compound. It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits. It's likely it was developed in 1994 or 1995 as the first clinical trials and peer-reviewed research articles appear in the literature in 1995.

Introduction:

- Idra-21 can increases in cognition
- Idra-21 can increased task accuracy
- Idra-21 can increases in short term memory
- Idra-21 can potential therapeutic effects on schizophrenia
- Idra-21 can potential therapeutic effects on depression
- Idra-21 can neuroprotection